Oncotargets And Therapy

Journal Title：Oncotargets And Therapy

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer.

The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype.

Specific topics covered by the journal include:

-Novel therapeutic targets and innovative agents

-Novel therapeutic regimens for improved benefit and/or decreased side effects

-Early stage clinical trials

Further considerations when submitting to OncoTargets and Therapy:

-Studies containing in vivo animal model data will be considered favorably.

-Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines.

-Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples.

-Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Single nucleotide polymorphism (SNP) studies will not be considered.

OncoTargets and Therapy 是一份国际同行评审期刊，专注于癌症研究的分子方面，即所有类型癌症的分子诊断和靶向分子或精准治疗。

该杂志的特点是快速报道高质量的原创研究、基础科学、评论和评估、专家意见和评论，从而为癌症或癌症亚型提供新的见解。

期刊涵盖的具体主题包括：

-新型治疗靶点和创新药物

-提高效益和/或减少副作用的新型治疗方案

-早期临床试验

提交 OncoTargets and Therapy 时的其他注意事项：

-将优先考虑包含体内动物模型数据的研究。

-除非得到涉及多个细胞系的综合生物学研究的支持，否则不会考虑组织微阵列分析。

-只有在通过全面的体外数据和人体组织样本分析验证后，才会考虑生物标志物关联研究。

-利用公开可用数据（例如 GWAS/TCGA/GEO 等）的研究应增加关于特定疾病或相关表型的知识体系，并且必须通过在独立样本集中复制使用作者自己的数据进行验证和功能跟进。

-生物信息学研究必须使用作者自己的数据通过在独立样本集中的复制和功能跟踪进行验证。

-不考虑单核苷酸多态性 (SNP) 研究。

Oncotargets And Therapy创刊于2008年，由DOVE MEDICAL PRESS LTD出版商出版，收稿方向涵盖BIOTECHNOLOGY & APPLIED MICROBIOLOGY - ONCOLOGY全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度较慢,6-12周，影响因子指数3.337，该期刊近期被列入国际期刊预警名单，请广大学者慎重选择。